FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989876214> ?p ?o ?g. }

• W2989876214 abstract "Abstract A strategy in the discovery of anti-tuberculosis (anti-TB) drug involves targeting the enzymes involved in the biosynthesis of Mycobacterium tuberculosis ’ ( Mtb ) cell wall. One of these enzymes is Galactofuranosyltransferase 2 (GlfT2) that catalyzes the elongation of the galactan chain of Mtb cell wall. Studies targeting GlfT2 have so far produced compounds showing minimal inhibitory activity. With the current challenge of designing potential GlfT2 inhibitors with high inhibition activity, computational methods such as molecular docking, receptor-ligand mapping, molecular dynamics, and Three-Dimensional-Quantitative Structure-Activity Relationship (3D-QSAR) were utilized to deduce the interactions of the reported compounds with the target enzyme and enabling the design of more potent GlfT2 inhibitors. Molecular docking studies showed that the synthesized compounds have binding energy values between −3.00 to −6.00 kcal mol −1 . Two compounds, #27 and #31, have registered binding energy values of −8.32 ± 0.01, and −8.08 ± 0.01 kcal mol −1 , respectively. These compounds were synthesized as UDP-Galactopyranose mutase (UGM) inhibitors and could possibly inhibit GlfT2. Interestingly, the analogs of the known disaccharide substrate, compounds #1–4, have binding energy range of −10.00 to −19.00 kcal mol −1 . The synthesized and newly designed compounds were subjected to 3D-QSAR to further design compounds with effective interaction within the active site. Results showed improved binding energy from −6.00 to −8.00 kcal mol −1 . A significant increase on the binding affinity was observed when modifying the aglycon part instead of the sugar moiety. Furthermore, these top hit compounds were subjected to in silico ADMETox evaluation. Compounds #31, #70, #71, #72, and #73 were found to pass the ADME evaluation and throughout the screening, only compound #31 passed the predicted toxicity evaluation. This work could pave the way in the design and synthesis of GlfT2 inhibitors through computer-aided drug design and can be used as an initial approach in identifying potential novel GlfT2 inhibitors with promising activity and low toxicity." @default.
• W2989876214 created "2019-12-05" @default.
• W2989876214 creator A5015853906 @default.
• W2989876214 creator A5017676356 @default.
• W2989876214 creator A5049814948 @default.
• W2989876214 creator A5074098805 @default.
• W2989876214 date "2019-11-19" @default.
• W2989876214 modified "2023-10-17" @default.
• W2989876214 title "Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies" @default.
• W2989876214 cites W1561210178 @default.
• W2989876214 cites W1576045095 @default.
• W2989876214 cites W17016395 @default.
• W2989876214 cites W1964658576 @default.
• W2989876214 cites W1966709219 @default.
• W2989876214 cites W1967992529 @default.
• W2989876214 cites W1971087365 @default.
• W2989876214 cites W1974044507 @default.
• W2989876214 cites W1974359669 @default.
• W2989876214 cites W1980498259 @default.
• W2989876214 cites W1980648455 @default.
• W2989876214 cites W2001192638 @default.
• W2989876214 cites W2006362240 @default.
• W2989876214 cites W2010401625 @default.
• W2989876214 cites W2014048624 @default.
• W2989876214 cites W2017001642 @default.
• W2989876214 cites W2021439946 @default.
• W2989876214 cites W2024410893 @default.
• W2989876214 cites W2029181779 @default.
• W2989876214 cites W2029314900 @default.
• W2989876214 cites W2030696214 @default.
• W2989876214 cites W2037013096 @default.
• W2989876214 cites W2038914630 @default.
• W2989876214 cites W2042679990 @default.
• W2989876214 cites W2046126967 @default.
• W2989876214 cites W2046620897 @default.
• W2989876214 cites W2049894993 @default.
• W2989876214 cites W2052219100 @default.
• W2989876214 cites W2055592341 @default.
• W2989876214 cites W2067174909 @default.
• W2989876214 cites W2070789802 @default.
• W2989876214 cites W2073830140 @default.
• W2989876214 cites W2078229483 @default.
• W2989876214 cites W2095085315 @default.
• W2989876214 cites W2096164927 @default.
• W2989876214 cites W2098546008 @default.
• W2989876214 cites W2103226619 @default.
• W2989876214 cites W2105840619 @default.
• W2989876214 cites W2106140689 @default.
• W2989876214 cites W2112293062 @default.
• W2989876214 cites W2113313056 @default.
• W2989876214 cites W2113364934 @default.
• W2989876214 cites W2117867368 @default.
• W2989876214 cites W2124826540 @default.
• W2989876214 cites W2134967712 @default.
• W2989876214 cites W2147479689 @default.
• W2989876214 cites W2148950790 @default.
• W2989876214 cites W2150981663 @default.
• W2989876214 cites W2154510076 @default.
• W2989876214 cites W2155335820 @default.
• W2989876214 cites W2156531683 @default.
• W2989876214 cites W2164183771 @default.
• W2989876214 cites W2165711991 @default.
• W2989876214 cites W2170977052 @default.
• W2989876214 cites W2172883944 @default.
• W2989876214 cites W2225235469 @default.
• W2989876214 cites W2325735934 @default.
• W2989876214 cites W2332712348 @default.
• W2989876214 cites W2503723997 @default.
• W2989876214 cites W2554099577 @default.
• W2989876214 cites W2593436234 @default.
• W2989876214 cites W2766035336 @default.
• W2989876214 cites W2766171755 @default.
• W2989876214 cites W2801088198 @default.
• W2989876214 cites W2805908886 @default.
• W2989876214 cites W282391397 @default.
• W2989876214 cites W2908328357 @default.
• W2989876214 cites W2923222668 @default.
• W2989876214 cites W2923725697 @default.
• W2989876214 cites W2927107056 @default.
• W2989876214 cites W2951445167 @default.
• W2989876214 cites W4240991862 @default.
• W2989876214 doi "https://doi.org/10.1038/s41598-019-52764-8" @default.
• W2989876214 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6863818" @default.
• W2989876214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31745103" @default.
• W2989876214 hasPublicationYear "2019" @default.
• W2989876214 type Work @default.
• W2989876214 sameAs 2989876214 @default.
• W2989876214 citedByCount "38" @default.
• W2989876214 countsByYear W29898762142020 @default.
• W2989876214 countsByYear W29898762142021 @default.
• W2989876214 countsByYear W29898762142022 @default.
• W2989876214 countsByYear W29898762142023 @default.
• W2989876214 crossrefType "journal-article" @default.
• W2989876214 hasAuthorship W2989876214A5015853906 @default.
• W2989876214 hasAuthorship W2989876214A5017676356 @default.
• W2989876214 hasAuthorship W2989876214A5049814948 @default.
• W2989876214 hasAuthorship W2989876214A5074098805 @default.
• W2989876214 hasBestOaLocation W29898762141 @default.
• W2989876214 hasConcept C104317684 @default.
• W2989876214 hasConcept C107824862 @default.

• next